4565.T Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 mai 2024 @ 02:30):

Stats
Dagens volum	85 400.00
Gjennomsnittsvolum	1.35M
Markedsverdi	132.20B
EPS	¥-2.13 ( 2024-02-13 )
Neste inntjeningsdato	( ¥35.75 ) 2024-05-08
Last Dividend	¥2.50 ( 2015-03-27 )
Next Dividend	¥0 ( N/A )
P/E	-16.95
ATR14	¥1.301 (0.09%)

Volum Korrelasjon

Lang: -0.26 (neutral)

Kort: -0.55 (weak negative)

Signal:(52.726) Neutral

Sosei Group Corporation Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Sosei Group Corporation Korrelasjon - Valuta/Råvare

-0.07
( neutral )

0.08
( neutral )

0.54
( weak )

-0.27
( neutral )

-0.06
( neutral )

-0.36
( neutral )

Sosei Group Corporation Økonomi

Annual	2023
Omsetning:	¥12.77B
Bruttogevinst:	¥7.87B (61.62 %)
EPS:	¥-87.17

FY	2023
Omsetning:	¥12.77B
Bruttogevinst:	¥7.87B (61.62 %)
EPS:	¥-87.17

FY	2022
Omsetning:	¥15.57B
Bruttogevinst:	¥14.64B (94.05 %)
EPS:	¥4.67

FY	2021
Omsetning:	¥17.71B
Bruttogevinst:	¥16.78B (94.73 %)
EPS:	¥12.53

Financial Reports:

No articles found.

Sosei Group Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Sosei Group Corporation Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	¥2.50	2015-03-27
Last Dividend	¥2.50	2015-03-27
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	¥2.50	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-05-01)

¥0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8060.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
7326.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
6571.T	Ex Dividend Junior	2024-06-27	Sporadic	0.00%
5929.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4595.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
3836.T	Ex Dividend Knight	2024-06-27	Annually	0.00%
3087.T	Ex Dividend Knight	2024-02-28	Semi-Annually	0.00%
1954.T	Ex Dividend Junior	2023-06-29	Annually	0.00%
9960.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8960.T	Ex Dividend Knight	2023-11-29	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.563	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.0458	1.200	-1.525	-1.830	[0 - 0.3]
returnOnEquityTTM	-0.117	1.500	-2.41	-3.62	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.79	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.57	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.86	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.445	-1.500	2.58	-3.87	[0 - 0.6]
interestCoverageTTM	-3.34	1.000	-2.35	-2.35	[3 - 30]
operatingCashFlowPerShareTTM	-58.95	2.00	-10.00	-10.00	[0 - 30]
freeCashFlowPerShareTTM	-68.47	2.00	-10.00	-10.00	[0 - 20]
debtEquityRatioTTM	1.048	-1.500	5.81	-8.71	[0 - 2.5]
grossProfitMarginTTM	0.697	1.000	1.723	1.723	[0.2 - 0.8]
operatingProfitMarginTTM	-0.692	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.0753	1.000	-1.530	-1.530	[0.2 - 2]
assetTurnoverTTM	0.0812	0.800	-2.79	-2.23	[0.5 - 2]
Total Score				-1.525

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-18.29	1.000	-1.949	0	[1 - 100]
returnOnEquityTTM	-0.117	2.50	-1.551	-3.62	[0.1 - 1.5]
freeCashFlowPerShareTTM	-68.47	2.00	-10.00	-10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-58.95	2.00	-10.00	-10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.292	1.500	-1.389	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.413	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-3.79

Sosei Group Corporation

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis. The company's product pipeline consists of HTL0022562, a calcitonin gene related peptide antagonist, which is in Phase I clinical study; HTL0016878 for neurological diseases; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; PF-07258669 for anorexia; and TMP301 and BHV3100 for neurological disorders, which is in clinical trials. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.